国际著名医药公司在印度与强大的仿制药品产业多番鏖战,结果往往是败下阵来。虽然印度从2005年起开始同意接受国际规则,对药品开始授予专利,但是事关生命健康的药品不应被少数人垄断这一观念,似乎依然作为传统根植于印度的立法、司法和行政文化。 International well-known pharmaceutical companies in India with the powerful generic drug industry repeatedly fought, the result is often defeated. Although India has agreed since 2005 to accept international rules to start patenting pharmaceuticals, the concept that life-saving medicines should not be monopolized by the few seems to remain the traditional legislative, judicial and administrative culture rooted in India.